Objective. To assess bone mineral content (BMC) status and serum vitam
in D metabolite levels of infants and children with chronic cholestati
c liver disease. To determine if severity of bone disease in these pat
ients correlates with serum vitamin D metabolite levels. Methodology.
We measured radial BMC with the use of a single-beam photon absorptiom
eter and serum vitamin D metabolite levels in 56 patients with chronic
cholestasis seen at our institution from 1985 through 1991. Patients
were divided into two groups according to age. Results. In group 1 (n
= 37; age 2 to 22 months), decreased levels of BMC were seen as early
as the first few months of life, with sharp decline observed with incr
easing age (approaching 3 to 5 standard deviations [SD] below the mean
, P < .0003). Older patients (group 2, n = 19; age 2 to 20 years) had
BMC values which clustered between 2 and 4 SD below the mean throughou
t the age range. Although a downward trend also was noted with increas
ing age, this was not statistically significant. Despite correction fo
r weight-age or height-age, BMC was decreased in most of these patient
s. No correlation between severity of osteopenia and serum levels of 2
5(OH)-vitamin D and 1,25(OH)2-vitamin D was observed in either infants
or older children. Conclusions. Decreased bone mineralization, as a c
omplication of chronic cholestatic conditions, is a disease process th
at begins early in infancy, rapidly worsens with increasing age and he
patic dysfunction, and remains relatively stable in children with more
stable liver disease.